Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors—and ...
Akeso Inc. (9926.HK) announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been officially approved by the National Medical Products Administration (NMPA) for ...
In this study, we demonstrated that there are in fact some genes without which a cancer cell cannot survive, making them ...
Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer.
Chinese scientists have announced that a new vaccine is in development to prevent plaque build-up in arteries, which leads to heart attacks and strokes. They are currently testing the vaccine on mice ...
The vaccine, developed by scientists at Nanjing University of Science and Technology, has shown promise in reducing the ...
The cocktail design of vaccine, tried on mice by Chinese scientists, mitigates the progression of fatty plaque in arteries ...
Head and neck cancers rank fifth in cancer-related mortality and often begin in the tongue, throat, or neck before metastasizing.
Prof. Dan Peer & research team. Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells ...